Drug for treatment of mild and moderate forms of coronavirus infection Karanvir developed by the company “R-farm”, will arrive on the market in July, said the Director of the Yaroslavl plant of finished dosage forms (branch of “R-Pharm”) Vladimir kolyshkin at a meeting with Russian President Vladimir Putin with representatives of the industries confronted with the consequences of the spread of coronavirus.
“Karanvir already submitted for registration to the Ministry of health. By early July, more than 150 thousand packs will arrive on the market” – leads TASS words Kolyshkin.
In April 2020, the General Director of “R-Pharm” Vasily Ignatyev announced that the company received approval of the Ministry of health on the clinical trial of two drugs for the treatment of severe coronavirus infection. Manufacture of a full cycle of both drugs, including biotechnological production of active substance manufacture of finished dosage forms, organized in the factory “R-Pharm” in Yaroslavl. The drugs arrived in Moscow and Saint Petersburg for distribution to clinics in April. According to Ignatiev, the volume of investments in the development of drugs exceeded 20 billion rubles.